Abstract
Since clarification of the relationship between Mikulicz’s disease and IgG4-related disease (IgG4-RD), basic research and clinical work on IgG4-RD in ophthalmology have progressed considerably, particularly with regard to the lacrimal gland lesions. Although it is clear that the lacrimal gland is the most common of the various orbital structures to be involved by IgG4-RD, other orbital structures are also involved with a high frequency, particularly the extraocular muscles and infraorbital nerve. Moreover, IgG4-related lesions may extend from the orbit to affect adjacent structures in the orbital apex, the lacrimal drainage system, and the eyeball. “IgG4-related ophthalmic disease” has been proposed as an appropriate term that encompasses disease involvement at all of these sites. Among inflammatory and lymphoproliferative disorders of the orbit, approximately one fourth appear to be associated with IgG4-RD.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
1 Introductory Remarks
Mikulicz’s disease, which is characterized by symmetrical swelling of the lacrimal and salivary glands, is a representative IgG4-related disease (IgG4-RD), for which the initial patient sketched in the “portrait of a farmer” by Mikulicz in his original publication has subsequently served as a virtual advertising poster for this disease. Because lacrimal glands are relatively easy to biopsy, basic research and pathological and clinical studies on IgG4-RD in the ophthalmic region have focused to a large extent on lesions in these organs. Recently, however, a growing understanding has developed of the frequency with which IgG4-RD involves not only the lacrimal gland but also other ocular adnexa such as the extraocular muscles and orbital nerves. Lacrimal gland lesions are described in detail in other chapters of this book. We therefore concentrate on orbital lesions other than the lacrimal gland.
Manifestations of IgG4-RD in the ophthalmic region are recognized with a frequency that is now surprising, given that IgG4-RD was identified as a distinct disease entity only within the past decade. In our collective experience, IgG4-RD appears to account for approximately 25 % of cases in which patients present with proptosis, eyelid swelling, and other features of orbital inflammation.
2 IgG4-RD in Orbital Inflammatory Disease
The most prominent pathological feature in IgG4-RD is lymphoplasmacytic cell infiltration. The differential diagnosis of orbital inflammatory and lymphoproliferative lesions includes malignant lymphoma, “reactive lymphoid hyperplasia,” “idiopathic orbital inflammation,” and “orbital pseudotumor.” Inflammatory and lymphoproliferative conditions comprise the largest group of mass-forming diseases in the orbit and account for more than 40 % of such lesions in Japan [1, 2]. Data available from the United States suggest a somewhat lower percentage, but the figure is still on the order of 20 % [3–5].
The most common lymphomas among the lymphoproliferative disorders that affect the orbit are MALT lymphomas (i.e., extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue), diffuse large B-cell lymphomas (DLBCL), and follicular lymphomas [4]. These low- and medium-grade tumors originate in the ophthalmic region and tend to preserve the shape of the eyeball and orbital bones, demonstrating a predilection for infiltrating the gaps between them (Fig. 12.1d, e).
Computed tomographic (CT) and magnetic resonance imaging (MRI) studies in orbital lymphoma typically demonstrate an absence of globe compression and bone destruction. The absence of destructive lesions facilitates differentiation of lymphomas from the other common orbital tumors such as pleomorphic adenoma (Fig. 12.1a), lacrimal gland cancer (Fig. 12.1b), and hemangioma (Fig. 12.1c). In contrast, the differentiation between lymphomas and non-tumorous lesions diagnostic imaging is sometimes difficult (Fig. 12.1d–f), and histopathological confirmation of the diagnosis, often aided by gene rearrangement studies, is essential.
A breakdown of the orbital inflammatory and lymphoproliferative disorders seen at the authors’ institutions is shown in Fig. 12.2. IgG4-RD accounts for approximately one quarter of the total. In general, serum IgG4 values are low and tissue immunostaining for IgG4 is negative in MALT lymphoma. However, prominent IgG4 staining has been reported in some cases of MALT lymphoma (Fig. 12.2). In addition, both the development of malignant lymphoma against a background of IgG4-related dacryoadenitis [6–8] and IgG4-producing MALT lymphomas [9] have also been described.
3 Diversity of IgG4-Related Lesions in the Ophthalmic Region
A pivotal event in the elaboration of the IgG4-RD concept was the discovery that serum IgG4 values are elevated in autoimmune pancreatitis. Subsequently, Mikulicz’s disease was reported to be IgG4-related [10, 11], prompting attention to be focused on systemic IgG4-related lesions in other organs. We focus the majority of our attention on IgG4-related involvement of orbital structures other than the lacrimal gland.
3.1 Extraocular Myositis
Extraocular muscle swelling is one of the most common IgG4-related orbital lesions after dacryoadenitis [12, 13]. Figure 12.3 illustrates representative cases of IgG4-related extraocular myositis. Swelling is seen in the superior, inferior, medial, and lateral rectus muscles and in the inferior oblique muscle (Fig. 12.3a–d). The pathology findings in the extraocular muscle are similar to those of IgG4-related dacryoadenitis, i.e., an IgG4-positive lymphoplasmacytic infiltrate associated with follicle formation and fibrosclerosis (Fig. 12.3e, f). The frequency of IgG4 extraocular myositis among patients with IgG4-related ophthalmic disease requires further investigation of larger numbers of patients. Biopsy of the extraocular muscles is seldom performed.
Graves’ ophthalmopathy, which can also affect multiple extraocular muscles, must be distinguished from IgG4-RD in this setting. Kubota et al. have reported a case in which IgG4-related orbital inflammation and thyroid ophthalmopathy occurred concomitantly [14], but this occurrence is considered to be coincidental.
3.2 Supraorbital and Infraorbital Nerve Swelling
In IgG4-RD, enlargement of the infraorbital nerve as well as of the infraorbital canal has recently been reported [13, 15, 16]. Lesions around the infraorbital nerve (Figs. 12.3c and 12.4b) and supraorbital nerve are seen in some cases (Figs. 12.3d and 12.4b). Although nerve tissue for pathological examination is difficult to obtain, Katsura et al. reported a perineural lymphoplasmacytic infiltration with foci of IgG4-positive plasma cells and fibrosis [16]. Numbness of the affected nerve appears to be common, but most patients are asymptomatic.
3.3 Lesions in the Muscle Cone
IgG4-RD lesions are sometimes seen in the muscle cone (the portion surrounded by the four rectus muscles) and around the optic nerve (Fig. 12.4a, b). Patients with such lesions are prone to exophthalmos (Fig. 12.4a). These lesions have been interpreted both as inflammation of the tissues surrounding the optic nerve (i.e., the optic nerve sheath) and as inflammation of the adipose tissues [13]. Perivascular lesions also form in the muscle cone in some patients (Fig. 12.4c, d).
3.4 IgG4-Related Optic Neuropathy
When lesions of IgG4-RD form near the optic canal, visual acuity and/or visual field impairment due to optic neuropathy may occur. Although this is attributed to compression near the optic canal (Fig. 12.5a, b), cases without masses are also encountered (Fig. 12.5c, d). Multiple mechanisms may contribute to this type of optic neuropathy.
4 Gray Zone of IgG4-Related Lesions in the Ophthalmic Region
The diagnosis of IgG4-RD requires the synthesis of clinical, serological, radiologic, and pathology data from a variety of potential organs that can be involved. As described elsewhere in this book, the pathology of IgG4-RD consists of foci of marked lymphoplasmacytic infiltration associated with fibrosclerosis, and a high percentage of plasma cells stain for IgG4. The serum IgG4 concentration is elevated in the majority of patients, but not all. It must be emphasized, however, that elevations neither in tissue nor in serum are diagnostic of IgG4-RD in and of themselves. For example, typical lacrimal gland cyst cases (Fig. 12.6a–d) can be associated with inflammatory cell infiltration by numerous IgG4-positive cells. This tissue specimen contains none of the other histopathological features of IgG4-RD, however, and it would therefore be erroneous (and dangerous) to render the diagnosis of IgG4-RD in this setting.
The majority of cases diagnosed with IgG4-related Mikulicz’s disease or IgG4-related dacryoadenitis are straightforward, demonstrating both serological and pathology characteristics that are strongly suggestive or diagnostic of IgG4-RD. In some patients, however, the diagnosis of IgG4-related dacryoadenitis is predicated upon pathological findings on biopsy in the setting of normal serum IgG4 concentrations (Fig. 12.6e, f).
The case shown in Fig. 12.6g, h illustrates the clinical variability of IgG4-RD. This 65-year-old diabetic man was diagnosed with IgG4-related dacryoadenitis on the basis of histopathological and immunostaining features of a lacrimal gland biopsy. At the time of diagnosis, his serum IgG4 concentration was 164 mg/dL (normal <121 mg/dL). Glucocorticoid treatment was withheld because of concern about its effects on his glucose metabolism, and he was followed with expectant management. Five years later, his serum IgG4 concentration had normalized (55 mg/dL) and the bilateral lacrimal gland swelling also decreased. This case demonstrates the variable natural history of IgG4-RD, its prolonged course, and its potential for spontaneous improvement in some patients. It also indicates that the diagnosis of IgG4-RD should be considered in the appropriate clinical setting despite normal serum IgG4 concentrations.
At the First Boston International Symposium on IgG4-RD, Cheuk et al. reported cases of chronic dacryoadenitis in which the serum IgG4 values were normal and IgG4-immunostaining was negative, but hematoxylin and eosin studies revealed a pathological picture of fibrosclerosis and lymphocyte infiltration with follicle formation (Cheuk et al., unpublished observation). We have also observed such cases. Cheuk et al. have referred to such cases as “IgG4-negative IgG4-RD.” Further investigation is required to understand the relationship of such cases, if any, to IgG4-RD.
4.1 Dacryocystitis and Lacrimal Ducts
Recently, cases of IgG4-related lacrimal duct lesions [17] and IgG4-related dacryocystitis [18] have been reported. Perhaps because lacrimal duct occlusive disease is not usually subjected to pathological examination, we have not encountered such cases at our institutions. More scrutiny needs to be devoted to these potential lesions in the future. Some cases of IgG4-RD are known to be complicated by sinusitis, and lacrimal duct lesions may develop in some of these cases similar to the manner observed in granulomatosis with polyangiitis (formerly Wegener’s).
4.2 Eyeball Lesions
In posterior scleritis, extreme inflammatory thickening of the sclera is sometimes seen. The pathophysiology of this lesion has not been adequately explained. Recently, a case with a prominent intraocular protrusive lesion that was subjected to enucleation because of a suspicion of malignant tumor was reported at a Japanese meeting (unpublished observation by Tsuji). Marked scleral thickening and IgG4-positive plasma cell infiltration were demonstrated on the enucleated eye, and a serum IgG4 concentration >130 mg/dL was documented. The fact that this patient had a history of retroperitoneal fibrosis was also consistent with the diagnosis of IgG4-RD. Another case with IgG4-related intraocular lesion was also reported [19]. In this case, enucleation of the eyeball was performed for the preliminary diagnosis of choroidal tumor.
4.3 Lesions of the Orbital Apex and Adjacent Structures of the Orbit
Cases are encountered in which extension of the disease to the orbital apex or other adjacent structures of the orbit occurs (Fig. 12.7a, b). When no superficial orbital lesions are present, histopathological diagnosis is extremely difficult to achieve. In this sense, these cases must be considered to have “gray zone” lesions. Depending on the degree of inflammatory cell infiltration into these tight spaces, marked visual impairment can result. Anecdotal reports have described cases in which excessive therapy such as enucleation of the eyeball or orbital exenteration was performed because of a suspicion of malignancy. Determination of the serum IgG4 value can be extremely important in such cases, but even a normal serum IgG4 concentration does not necessarily rule out IgG4-RD.
5 Nomenclature Encompassing All Lesions in the Ophthalmic Region: IgG4-Related Ophthalmic Disease
Bilateral lacrimal gland swelling is indisputably a typical manifestation of IgG4-RD in the ophthalmic region. However, it has become apparent that IgG4-related lesions exhibit diverse infiltrative patterns and can also involve the extraocular muscles, nerves, and other structures. Although the assignment of names to each of these lesions would be possible—e.g., “IgG4-related extraocular muscle lesions” or “IgG4-related orbital nerve lesions”—the proliferation of names would merely complicate issues of nomenclature, to little purpose. An international consensus document on the nomenclature of IgG4-RD recently recommended “IgG4-related ophthalmic disease” as the broader name for all complications of this disease occurring in this region [20]. However, this summary term does not preclude the use of more precise terminology, e.g., IgG4-related dacryoadenitis, when such anatomic specificity is required.
References
Goto H. Review of ocular tumor. In: Goto H, editor. Practical ophthalmology (Japanese), vol. 24. Tokyo: Bunkodo; 2008. p. 2–9.
Ohtsuka K, Hashimoto M, Suzuki Y. A review of 244 orbital tumors in Japanese patients during a 21-year period: origins and locations. Jpn J Ophthalmol. 2005;49:49–55.
Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: the 2002 Montgomery Lecture, part I. Ophthalmology. 2004;111:997–1008.
McKelvie PA. Ocular adnexal lymphomas: a review. Adv Anat Pathol. 2010;17:251–61.
Shinder R, Al-Zubidi N, Esmaeli B. Survey of orbital tumors at a comprehensive cancer center in the United States. Head Neck. 2011 May;33(5):610–4.
Sato Y, Ohshima K, Ichimura K, et al. Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol Int. 2008;58:465–70.
Cheuk W, Yuen HK, Chan JK. Complication of IgG4-related chronic sclerosing dacryoadenitis by lymphoma. Arch Ophthalmol. 2008;126:1170.
Oyama T, Takizawa J, Nakamura N, et al. Multifocal mucosa-associated lymphoid tissue lymphoma associated with IgG4-related disease: a case report. Jpn J Ophthalmol. 2011;55:304–6.
Sato Y, Takata K, Ichimura K, et al. IgG4-producing marginal zone B-cell lymphoma. Int J Hematol. 2008;88:428–33.
Yamamoto M, Harada S, Ohara M, et al. Clinical and pathological differences between Mikulicz’s disease and Sjögren’s syndrome. Rheumatology. 2005;44:227–34.
Takahira M, Kawano M, Zen Y, et al. IgG4-related chronic sclerosing dacryoadenitis. Arch Ophthalmol. 2007;125:1575–8.
Kubota T, Moritani S, Katayama M, Terasaki H. Ocular adnexal IgG4-related lymphoplasmacytic infiltrative disorder. Arch Ophthalmol. 2010;128:577–84.
Wallace ZS, Khosroshahi A, Jakobiec FA, et al. IgG4-related systemic disease as a cause of “idiopathic” orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophthalmol. 2012;57:26–33.
Kubota T, Moritani S, Terasaki H. Ocular adnexal IgG4-related lymphoplasmacytic infiltrative disorder and Graves ophthalmopathy. Arch Ophthalmol. 2011;129:818–9.
Mehta M, Jakobiec F, Fay A. Idiopathic fibroinflammatory disease of the face, eyelids, and periorbital membrane with immunoglobulin G4-positive plasma cells. Arch Pathol Lab Med. 2009;133:1251–5.
Katsura M, Morita A, Horiuchi H, et al. IgG4-related inflammatory pseudotumor of the trigeminal nerve: another component of IgG4-related sclerosing disease? Am J Neuroradiol. 2011;32:E150–2.
Suzuki M, Mizumachi T, Morita S, Kubota K, Iizuka K. A case of immunoglobulin 4-related disease with bilateral mass-forming lesions in the nasolacrimal ducts. J Clin Rheumatol. 2011;17:207–10.
Batra R, Mudhar HS, Sandramouli S. A unique case of IgG4 sclerosing dacryocystitis. Ophthal Plast Reconstr Surg. 2012;28:e70–2.
Ohno K, Sato Y, Ohshima KI, Takata K, Ando M, Abd Al-Kader L, Iwaki N, Takeuchi M, Orita Y, Yoshino T. IgG4-related disease involving the sclera. Mod Rheumatol. 2012 Sep 16. [Epub ahead of print]
Stone JH, Khosroshahi A, Deshpande V, et al. IgG4-Related disease: recommendations for the nomenclature of this condition and its individual organ system manifestations. Arthritis Rheum. 2012;64:3061–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Japan
About this chapter
Cite this chapter
Takahira, M., Azumi, A. (2014). Ophthalmology. In: Umehara, H., Okazaki, K., Stone, J., Kawa, S., Kawano, M. (eds) IgG4-Related Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54228-5_12
Download citation
DOI: https://doi.org/10.1007/978-4-431-54228-5_12
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54227-8
Online ISBN: 978-4-431-54228-5
eBook Packages: MedicineMedicine (R0)